10-Year registry to track safety of weekly growth hormone in kids
NCT ID NCT06709040
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This 10-year observational study will follow 500 children with growth hormone deficiency who are receiving the once-weekly injection somapacitan as part of their routine care. Researchers will track side effects, medication errors, and new cases of cancer or type 2 diabetes. The goal is to understand the long-term safety and real-world effectiveness of this treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- somapacitan (a once-weekly growth hormone injection)
- What this could lead to
- If successful, this study will confirm that somapacitan is safe and effective for long-term use in children with growth hormone deficiency, supporting its continued use in routine care.
- What could go wrong
- This is an observational registry study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in how doctors prescribe the drug. The 10-year duration means final results are far off.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Glasgow
Glasgow, Scotland, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple screening program could transform cancer aftercare
- A new program aims to ease the 'Lost in Transition' struggle for cancer survivors
- Can a heart drug tame blood sugar and weight in diabetes?
- Can a puff of insulin replace a needle for diabetes?
- Could a quick insulin shot stop Steroid-Induced blood sugar spikes?
- Can a new immune drug outsmart Hard-to-Treat tumors?